Partnerships

Challenges for 2021:

GROWTH TRACK

This track is designed for companies in the early-mid stage (Pre-seed- Series A). Ideal candidates are seed-Series A startups with a Minimal Viable Product validated through patents and publications. And of course, a stellar and diverse team!

Startup companies will be offered EUR 75,000 in convertible loan. In addition to healthcare technology funding, we provide a dedicated workspace (Berlin, DE) and mentorship from industry experts.

ADVANCE TRACK

The Advance Track is designated for mature companies with a product or a solution already in the market with traction. Companies selected for this track will be working jointly with Bayer experts to drive a commercial partnership.

Exclusive Networking Opportunities

As part of G4A, you get to network with key people that can help you grow your business. You'll also have the opportunity to participate in meetup events, meet startegic partners, and form partnerships with fellow health tech experts that will be mutually beneficial.

Executive Mentors

In addition to close collaboration Pharmaceutical and digital health experts, our startups are paired with senior Bayer executives as their very own mentors throughout the duration of the program. This multi-level approach to mentoring provides invaluable insight and opportunities that last well beyond the cohort.

Regional Engagement

Support from the G4A team never ends. You become a G4A partner for life and join the G4A Alumni family!

That said, you automatically join a network of hundreds of like-minded people who continue to change the experience of health. Whether it's through event attendance, conference promotion of your innovative solutions or features in internal and external communications, G4A is dedicated to ensuring you succeed.

Latest from the Blog

April 6, 2021

The Role of Digital in Filling Growing Healthcare Demand

The mental health crisis in the United States has long been brewing with known barriers to care, including limited access, affordability, and stigma. In 2017, well before the COVID-19 pandemic, a quarter of adults with mental illness reported unmet needs for mental health treatment, and 60% of young people with major depression did not receive treatment.

Over the past year, the pandemic's prolonged and wide-spread isolation has amplified both the mental health crisis and the challenges of treating chronic diseases. The inter-relationship between mental health and chronic diseases has only become more evident as Americans find themselves shouldering the stress and anxiety of new realities like social distancing, shelter-in-place orders, unemployment, and illness.

SEE BLOG